These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3579908)

  • 41. Campylobacter pyloridis, urease, hydrogen ion back diffusion, and gastric ulcers.
    Hazell SL; Lee A
    Lancet; 1986 Jul; 2(8497):15-7. PubMed ID: 2873317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of cultural techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa.
    Goodwin CS; Blincow ED; Warren JR; Waters TE; Sanderson CR; Easton L
    J Clin Pathol; 1985 Oct; 38(10):1127-31. PubMed ID: 3902897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unusual cellular fatty acids and distinctive ultrastructure in a new spiral bacterium (Campylobacter pyloridis) from the human gastric mucosa.
    Goodwin CS; McCulloch RK; Armstrong JA; Wee SH
    J Med Microbiol; 1985 Apr; 19(2):257-67. PubMed ID: 3981612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ammonia produced by Campylobacter pylori neutralizes H+ moving through gastric mucus.
    Thomsen L; Tasman-Jones C; Morris A; Wiggins P; Lee S; Forlong C
    Scand J Gastroenterol; 1989 Aug; 24(6):761-8. PubMed ID: 2814342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Campylobacter pylori in patients with chronic gastritis and gastric and duodenal peptic ulcer].
    Kolarski V; Tsenova V; Shopova K; Vasileva E; Petrova D
    Vutr Boles; 1989; 28(2):58-62. PubMed ID: 2763525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Campylobacter pyloridis: the etiologic agent of gastritis and peptic ulcer?].
    Zeitune JM; Iriya K; Massuda HK; Bettarello A
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(2):35-8. PubMed ID: 3327134
    [No Abstract]   [Full Text] [Related]  

  • 47. [Campylobacter pyloridis in active chronic gastritis and peptic ulcer].
    Huang WK; Chen PH; Chen RC; Lin KY; Ko FT; Sheih IJ; Chang JG; Tseng HH; Lee LS
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 May; 20(2):148-53. PubMed ID: 3652784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Campylobacter pyloridis: opportunist or pathogen in the upper gastrointestinal tract].
    Ottenjann R; Bayerdörffer E
    Wien Med Wochenschr; 1987 Jun; 137(10-11):258-9. PubMed ID: 3604223
    [No Abstract]   [Full Text] [Related]  

  • 49. [Campylobacter pyloridis and its role in the development and clinical course of peptic ulcer and chronic erosive gastritis].
    Saenko VF; Pustovit AA; Medvetskiĭ ; Gorshevikova EV; Buryĭ AN
    Klin Khir (1962); 1988; (2):13-6. PubMed ID: 3373960
    [No Abstract]   [Full Text] [Related]  

  • 50. Sulglycotide effect on the proteolytic and lipolytic activities of Helicobacter pylori toward gastric mucus.
    Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A; Slomiany BL
    Am J Gastroenterol; 1994 Feb; 89(2):232-6. PubMed ID: 8304309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Essential components of antimicrobial gastrointestinal epithelial barrier: specific interaction of mucin with an integral apical membrane protein of gastric mucosa.
    Slomiany A; Grabska M; Slomiany BL
    Mol Med; 2001 Jan; 7(1):1-10. PubMed ID: 11474122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Iatrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria.
    Graham DY; Alpert LC; Smith JL; Yoshimura HH
    Am J Gastroenterol; 1988 Sep; 83(9):974-80. PubMed ID: 3414650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The validity of the ethanol precipitation method for the measurement of mucin content in human gastric juices and its possible relationship to gastroduodenal diseases.
    Azuumi Y; Ichikawa T; Ishihara K; Hotta K
    Clin Chim Acta; 1993 Nov; 221(1-2):219-25. PubMed ID: 8149639
    [No Abstract]   [Full Text] [Related]  

  • 54. [The role of Campylobacter pylori in the clinical course of chronic antral gastritis and duodenal ulcer].
    Kalinin AV; Spesivtsev VN; Sedletskiĭ VA; Belogolovtsev VA
    Klin Med (Mosk); 1989 Oct; 67(10):64-6. PubMed ID: 2615309
    [No Abstract]   [Full Text] [Related]  

  • 55. [Campylobacter pyloridis in duodenal ulcer].
    Loginov AS; Smotrova IA; Il'chenko AA; Aruin LI
    Sov Med; 1989; (3):3-6. PubMed ID: 2734670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.
    McNulty CA; Gearty JC; Crump B; Davis M; Donovan IA; Melikian V; Lister DM; Wise R
    Br Med J (Clin Res Ed); 1986 Sep; 293(6548):645-9. PubMed ID: 3092967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Campylobacter pyloridis in chronic gastritis and peptic ulcer].
    Grigor'ev PIa; Elisova NV; Isakov VA; Drozdov OV; Iakovenko EP
    Sov Med; 1988; (6):99-100. PubMed ID: 3187687
    [No Abstract]   [Full Text] [Related]  

  • 58. Campylobacter pyloridis: what role in gastritis and peptic ulcer.
    Axon AT
    Br Med J (Clin Res Ed); 1986 Sep; 293(6550):772-3. PubMed ID: 3094652
    [No Abstract]   [Full Text] [Related]  

  • 59. Interaction of microbes with mucus and mucins: recent developments.
    Naughton J; Duggan G; Bourke B; Clyne M
    Gut Microbes; 2014; 5(1):48-52. PubMed ID: 24149677
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of sucralfate on the degradation of human gastric mucus by Helicobacter pylori protease and lipases.
    Slomiany BL; Piotrowski J; Slomiany A
    Am J Gastroenterol; 1992 May; 87(5):595-9. PubMed ID: 1595646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.